Lorven Technologies Inc. · 1 day ago
Business Analyst - Bay Area, CA (Hybrid)
Lorven Technologies Inc. is seeking a Business Analyst for a long-term project. The role requires expertise in commercial analytics within the pharmaceutical or biotechnology sector, along with strong communication skills to relay complex data findings.
Responsibilities
Proven ability to communicate complex data findings to non-technical audiences
Strong skills in test case creation, defect tracking, and test documentation
Excellent communication and collaboration skills
Qualification
Required
Bachelor's degree in Business, Statistics, Economics, Life Sciences, Data Science, or related quantitative field
Industry Experience: commercial analytics experience in the pharmaceutical or biotechnology sector
Experience in Data Tools: Expert-level SQL skills for data extraction and transformation
Proficiency in Data Visualization tools (Power BI, Tableau)
IQVIA Proficiency: Strong, hands-on experience with IQVIA datasets (DDD, NPA, LAAD, MIDAS)
Technical Skills: Advanced Excel skills (modeling, VLOOKUP, pivot tables)
Experience with R or Python for advanced analytics is a plus
Functional Knowledge: Strong understanding of pharmaceutical commercial metrics (TRx, NRx, NBRx, Patient Days, Market Share)
Communication: Proven ability to communicate complex data findings to non-technical audiences
Strong skills in test case creation, defect tracking, and test documentation
Excellent communication and collaboration skills
Company
Lorven Technologies Inc.
Lorven Technologies, Inc. is a highly recognized provider of professional technology consultancy in the US.
H1B Sponsorship
Lorven Technologies Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (11)
2023 (13)
2022 (14)
2021 (12)
2020 (17)
Funding
Current Stage
Late StageCompany data provided by crunchbase